A detailed history of First Horizon Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 831 shares of NBIX stock, worth $103,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
831
Previous 782 6.27%
Holding current value
$103,027
Previous $107,000 6.54%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$130.86 - $143.19 $6,412 - $7,016
49 Added 6.27%
831 $114,000
Q4 2023

Feb 06, 2024

BUY
$106.07 - $132.76 $7,849 - $9,824
74 Added 10.45%
782 $103,000
Q2 2023

Aug 03, 2023

SELL
$89.53 - $104.87 $984 - $1,153
-11 Reduced 1.53%
708 $66,000
Q4 2022

Feb 10, 2023

BUY
$106.72 - $127.06 $6,936 - $8,258
65 Added 9.94%
719 $85,000
Q3 2022

Nov 09, 2022

SELL
$92.03 - $107.81 $4,141 - $4,851
-45 Reduced 6.44%
654 $69,000
Q2 2022

Aug 02, 2022

BUY
$75.79 - $100.07 $14,475 - $19,113
191 Added 37.6%
699 $68,000
Q1 2022

May 10, 2022

SELL
$72.45 - $94.81 $30,501 - $39,915
-421 Reduced 45.32%
508 $48,000
Q4 2021

Feb 09, 2022

SELL
$79.65 - $106.22 $8,203 - $10,940
-103 Reduced 9.98%
929 $79,000
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $12,496 - $14,359
-145 Reduced 12.32%
1,032 $98,000
Q3 2021

Nov 09, 2021

BUY
$86.18 - $99.03 $38,694 - $44,464
449 Added 61.68%
1,177 $112,000
Q2 2021

Aug 09, 2021

BUY
$89.43 - $102.27 $4,292 - $4,908
48 Added 7.06%
728 $70,000
Q1 2021

May 11, 2021

BUY
$87.57 - $119.4 $1,050 - $1,432
12 Added 1.8%
680 $66,000
Q4 2020

Feb 11, 2021

BUY
$86.91 - $108.33 $21,292 - $26,540
245 Added 57.92%
668 $64,000
Q3 2020

Nov 12, 2020

BUY
$96.16 - $135.15 $23,847 - $33,517
248 Added 141.71%
423 $40,000
Q1 2020

May 05, 2020

BUY
$75.11 - $113.76 $2,854 - $4,322
38 Added 27.74%
175 $15,000
Q3 2019

Oct 23, 2019

SELL
$83.82 - $101.5 $586 - $710
-7 Reduced 4.86%
137 $12,000
Q1 2019

Apr 26, 2019

BUY
$69.31 - $91.53 $9,980 - $13,180
144 New
144 $0

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.